Theraclion Share Price
Stocks
ALTHE
FR0010120402
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Euronext Paris
16:55:00 18/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.5840 EUR | +0.34% |
|
-11.52% | -2.99% |
| 11-06 | Theraclion's Ultrasound Platform Sonovein Wins De Novo Marketing Approval in US | MT |
| 11-05 | Theraclion authorized to market its varicose vein treatment in the United States |
| Market Cap | 42.55M 46.65M 39.34M 35.5M 66.87M 4.36B 69.5M 475M 188M 2.35B 175M 171M 7.43B | P/E 2026 * |
-5.78x | P/E 2027 * | -5.78x |
|---|---|---|---|---|---|
| Enterprise Value | 46.05M 50.49M 42.58M 38.42M 72.37M 4.72B 75.22M 514M 203M 2.55B 189M 185M 8.04B | EV / Sales 2026 * |
35.4x | EV / Sales 2027 * | 13.1x |
| Free-Float |
32.52% | Yield 2026 * |
-
| Yield 2027 * | - |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALTHE | Real-time | |
| 941 | Delayed | ||
| Real-time | |||
| 941 | Real-time | ||
| 941 | Delayed | ||
| Real-time |
| 1 day | +0.34% | ||
| 1 week | -11.52% | ||
| Current month | -16.57% | ||
| 1 month | +2.82% | ||
| 3 months | -8.75% | ||
| 6 months | +19.79% | ||
| Current year | -2.99% |
| 1 week | 0.56 | 0.66 | |
| 1 month | 0.51 | 0.85 | |
| Current year | 0.4 | 0.93 | |
| 1 year | 0.4 | 0.93 | |
| 3 years | 0.14 | 1.25 | |
| 5 years | 0.14 | 1.66 | |
| 10 years | 0.14 | 6.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Martin Deterre
CEO | Chief Executive Officer | - | 23/05/2023 |
Julie Veisseire
DFI | Director of Finance/CFO | - | - |
Alexandra Rocher
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Mehdi El Glaoui
BRD | Director/Board Member | - | 21/06/2021 |
Cédric Bellanger
BRD | Director/Board Member | - | 27/01/2022 |
Lijuan Deng
BRD | Director/Board Member | - | 28/06/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 26/08/26 | Exercice | Director | 266,139 | 0.3627% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.34% | -11.52% | -13.35% | +16.80% | 46.87M | ||
| +0.47% | -3.53% | +20.20% | +47.62% | 254B | ||
| +1.08% | -2.71% | +1.51% | +8.48% | 159B | ||
| -1.16% | -5.08% | -22.08% | +36.85% | 149B | ||
| +1.53% | -2.89% | -55.83% | -19.53% | 62.37B | ||
| -0.57% | -0.62% | +25.12% | +56.50% | 60.62B | ||
| +1.25% | +0.74% | +5.46% | -12.32% | 53.05B | ||
| +2.33% | -0.23% | +22.73% | +54.89% | 48.55B | ||
| -4.08% | -8.43% | +1.96% | +56.17% | 46.7B | ||
| +3.37% | -1.03% | +23.74% | +78.61% | 44.21B | ||
| Average | +0.53% | -3.03% | +0.95% | +32.41% | 88B | |
| Weighted average by Cap. | +0.44% | -3.00% | +3.03% | +33.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.3M 1.43M 1.2M 1.08M 2.04M 133M 2.12M 14.52M 5.74M 71.9M 5.35M 5.24M 227M | 3.6M 3.95M 3.33M 3M 5.66M 369M 5.88M 40.2M 15.89M 199M 14.81M 14.5M 629M |
| Net income | -6.3M -6.91M -5.82M -5.26M -9.9M -646M -10.29M -70.35M -27.81M -348M -25.92M -25.37M -1.1B | -6.6M -7.24M -6.1M -5.51M -10.37M -676M -10.78M -73.7M -29.13M -365M -27.15M -26.58M -1.15B |
| Net Debt | 3.5M 3.84M 3.24M 2.92M 5.5M 359M 5.72M 39.08M 15.45M 194M 14.4M 14.1M 611M | 4.6M 5.04M 4.25M 3.84M 7.23M 471M 7.51M 51.37M 20.31M 254M 18.92M 18.53M 803M |
Employees
36
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/11/26 | €0.5840 | +0.34% | 14,660 |
| 17/11/26 | €0.5820 | +0.34% | 37,220 |
| 16/11/26 | €0.5800 | -2.36% | 67,171 |
| 13/11/26 | €0.5940 | -6.31% | 220,776 |
| 12/11/26 | €0.6340 | -3.94% | 41,234 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6411USD
Average target price
2.230USD
Spread / Average Target
+247.83%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALTHE Stock
Select your edition
All financial news and data tailored to specific country editions
















